An international research consortium with the participation of the German Center for Neurodegenerative Diseases (DZNE) and the Bonn University Hospital has identified 11 previously unknown genetic risk factors for Alzheimer's disease.
The genome of over 25,000 patients as well as more than 48,000 healthy controls was analyzed to this end. The results have been published in the scientific journal “Nature Genetics”.
Alzheimer’s disease is a common cause of dementia. It is triggered by the death of brain cells and occurs in two variants: The so-called familial variant is relatively rare. It is caused by certain mutations in the genome and usually manifests itself already before the age of 65. However, more than 90 percent of the cases occur at an older age. The exact causes of this “sporadic” form of the disease are enigmatic. However, it is known that a disease may be favored by genetic traits, even though it may not necessarily be triggered by it.
So far, 11 such risk factors were known. A further 11 have now been identified by a team of researchers from the US and Europe. For this several universities and research institutions collaborated within the framework of the “International Genomics of Alzheimer's Project” (IGAP).
Large amounts of data
“Such an endeavor is enormously complex and requires the cooperation of many partners. We in particular contributed clinical data. This included anonymous genetic data of about one thousand patients that are diagnosed with Alzheimer’s disease,” says Dr. Alfredo Ramirez, who is a researcher at the Department of Psychiatry and Psychotherapy of Bonn University Hospital.
The memory clinic played an important role, explains Professor Frank Jessen, who is Deputy Director of the Department of Psychiatry and Psychotherapy and also a researcher affiliated to the DZNE: “Longtime preparations are needed for such a study. On the basis of our memory clinic we have been in touch with people diagnosed with memory disorders for many years. Through this we have been able to build up an extensive repository of genetic data from patients. We made this data available for the study.”
“In the case of such genetic studies, it is ultimately a matter of comparing the genomes of patients and controls,” explains Dr. Tim Becker from the Bonn site of the DZNE. Within the framework of the now published study he focused in particular on the analysis of genetic data. “We searched for genetic traits that are prevalent in persons that have been diagnosed with the disease. In order to do so, genetic data from many people has to be compared. This is the only way to obtain meaningful results and to distinguish random signals from real findings.”
Important contributions also came from the Institute of Human Genetics of the Bonn University Hospital. “We genotyped samples of DNA. This is very similar to doing genetic fingerprinting,” says Professor Markus Nöthen, head of the Institute.
Screening the genome
The IGAP consortium studied the genome of a total of 74,046 people. Of these, more than 25,000 were diagnosed with Alzheimer’s disease, the others were controls. High performance computing assisted in the analysis of the huge amount of data.
Pivotal to the research were so-called genome-wide association studies (GWAS). The genome, with its billions of building blocks, was thereby not fully cataloged, but instead only examined at relevant positions. This type of screening saves time and money, while at the same time providing a good coverage. The researchers examined about seven million positions.
“We identified eleven positions in the human genome that were previously largely ignored. However, if certain alterations are present there, the probability of developing Alzheimer’s increases,” says Becker. “Yet, this increased risk does not necessarily lead to disease.”
So far the researchers do not yet know in detail what role the affected regions play. “Some of these genes are related to Amyloid-beta and tau proteins that are known to be relevant for the Alzheimer’s disease. With regard to the other critical regions, we can not say with certainty what role they play”, says Ramirez. “We assume that they have an effect, for example, on nervous connections and on transport processes occurring inside the nerve cells. In addition, the immune system seems to be involved. As a next step, it will be important to investigate this in more detail.”Original publication
Dr. Marcus Neitzert | idw
First time-lapse footage of cell activity during limb regeneration
25.10.2016 | eLife
Phenotype at the push of a button
25.10.2016 | Institut für Pflanzenbiochemie
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
25.10.2016 | Earth Sciences
25.10.2016 | Life Sciences
25.10.2016 | Earth Sciences